Αρχική World News News digest – skin cancer deaths, Public Health England plans and ‘one-shot’...

News digest – skin cancer deaths, Public Health England plans and ‘one-shot’ radiotherapy

Hancock makes plans for Public Health England ‘to be replaced’

Matt Hancock plans to replace Public Health England (PHE) following claims that ministers are unhappy with the way PHE has responded to the pandemic. Reported in the Sunday Telegraph (£) and picked up by BBC News, the Health Secretary will be replacing PHE with a national agency that specialises in protecting the country from future pandemics. But despite the announcement, there’s still a lot we don’t know about the plans, which have been criticised as ‘risky and unjust’, as The Guardian explains.

150% rise in UK skin cancer deaths since 1970

The latest figures on skin cancer deaths, reported in our press release, reveal a 150% rise in skin cancer death rates since the 1970s. And the majority of cases are linked to overexposure to the sun, or using sunbeds. The results come with new warnings that approximately 4 in 10 UK adults say they have spent more time in the sun since the COVID-19 lockdown started, compared with the same time last year. Find out more at Sky News and the Evening Express.

Adverts banned as part of government’s new obesity strategy

Advertisements of foods that have more than 1.5g of salt – including sausage rolls and ketchup – may be banned from television before the 9pm watershed, reports the Daily Mail. It’s all part of the Government’s new obesity strategy, which was announced last month.

Patients with breast cancer respond well to ‘one-shot’ radiotherapy

New research picked up by the Guardian suggests that women with breast cancer who receive a single dose of radiotherapy during surgery, respond just as well as those who have up to 30 doses over 3 to 6 weeks. Here’s what our head information nurse, Martin Ledwick, had to say about the study.

Reducing the number of treatments and hospital visits is a good thing for patients. But as the women taking part in the study received radiotherapy at the same time as having a lumpectomy, doctors weren’t able to analyse their tumours in advance to see if they would need a longer course of radiotherapy until after their operation. While 20% of the women in this study did then need additional treatment, 80% of patients were spared this.

– Martin Ledwick, Cancer Research UK’s head information nurse.

Non-Hodgkin lymphoma treatment gets the green light for NHS use in England

Good news this week, as the National Institute for Health and Care Excellence (NICE) recommended a new combination therapy for adults with diffuse large B cell lymphoma on the NHS in England. After the initial rejection in March, a combination of polatuzumab vedotin (Polivy) and 2 existing cancer drugs will now be an option for people whose cancer has either not responded to, or come back after, initial treatment, and who are unable to have a stem cell transplant.

The team tackling the serious side effects of cancer treatment in an ageing population

By 2066, it’s predicted that around a quarter of the total UK population will be over 65 years old. And as life expectancy increases, an ageing population brings up a whole host of new challenges for healthcare, including the side effects of cancer treatments, which can often be experienced more intensely by older patients. Read more about the link between gut bacteria, fibre and radiotherapy in our latest blog post.

US lung cancer data points to the power of cancer research

New data from the US shows that deaths from non small cell lung cancer, the most common type of lung cancer, are decreasing. Deaths from non small cell lung cancer among US men dropped by 3.2% each year between 2006-2013, and by 6.3% between 2013-2016. In our blog post, we reflect on the impact of new targeted therapies.

And finally…

As we age, our chances of getting cancer increase, largely due to our exposure to cancer-causing agents, such as smoking and sun exposure. But new research, published in Nature, found that some of these harmful substances can be produced by our bodies as we age. They’ve discovered that a molecule produced during protein and fat digestion, which accumulates in the blood over time, may promote the spread of tumours.


More on this topic



Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...


Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...


ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Overall Breast Cancer Incidence Down Since 1999, Rates Increase for Women Under 40

U.S. breast cancer death rates decreased by about 1% per year between 2013 and 2018. What were the new case rates during that same...

Impressive Responses to PD-1 Blockade in a Large Cohort of Children and Young Adults with Recurrent/Progressive Germline DNA Replication Repair-Deficient Cancers

A large, observational, registry-based study that leveraged systematically collected data gathered both retrospectively and prospectively through the International Replication Repair Deficiency Consortium reveals impressive...

2-Year-Boy Is So Excited To See Himself In Disney’s ‘Encanto’

The importance of representation in media has been a growing topic of concern, and companies have responded by adding more diversity to their characters,...

Man Walks Entire Continent To Spread Awareness About Mental Health & Suicide Prevention

Matthew Fennell is walking over 3,000 miles across Australia for an important cause and one that is near and dear to his heart. Last year,...

Boy Battling Cancer Becomes Honorary Police Officer, Sworn In To 45 Agencies

At just ten years old, Devarjaye “DJ” Daniel has already been through more than most people go through in their entire lives. DJ has been...

Paclitaxel and Carboplatin Not Inferior When Compared with Paclitaxel and Ifosfamide for the Treatment of Patients with Uterine Carcinosarcoma

With regard to overall survival (OS), paclitaxel and carboplatin was not inferior and demonstrated improved progression-free survival (PFS) when compared with paclitaxel and ifosfamide...